Monozygotic twins with one chorion and two amnions are the result of division between days 4 and 8 after fertilization. This type of twinning has diamniotic, monochorionic placentation. Division between days 8 and 12 after fertilization leads to monozygotic twins with monoamniotic, monochorionic placentation, while fertilization of two separate eggs with two separate sperm results in dizygotic twins with diamniotic, dichorionic placentation. It’s important to note that division between days 4 and 8 after fertilization does not result in dizygotic twins.

Twin Pregnancies: Incidence, Types, and Complications

Twin pregnancies occur in approximately 1 out of 105 pregnancies, with the majority being dizygotic or non-identical twins. Monozygotic or identical twins, on the other hand, develop from a single ovum that has divided to form two embryos. However, monoamniotic monozygotic twins are associated with increased risks of spontaneous miscarriage, perinatal mortality rate, malformations, intrauterine growth restriction, prematurity, and twin-to-twin transfusions. The incidence of dizygotic twins is increasing due to infertility treatment, and predisposing factors include previous twins, family history, increasing maternal age, multigravida, induced ovulation, in-vitro fertilisation, and race, particularly Afro-Caribbean.

Antenatal complications of twin pregnancies include polyhydramnios, pregnancy-induced hypertension, anaemia, and antepartum haemorrhage. Fetal complications include perinatal mortality, prematurity, light-for-date babies, and malformations, especially in monozygotic twins. Labour complications may also arise, such as postpartum haemorrhage, malpresentation, cord prolapse, and entanglement.

Management of twin pregnancies involves rest, ultrasound for diagnosis and monthly checks, additional iron and folate, more antenatal care, and precautions during labour, such as having two obstetricians present. Most twins deliver by 38 weeks, and if longer, most are induced at 38-40 weeks. Overall, twin pregnancies require close monitoring and management to ensure the best possible outcomes for both mother and babies.

Placental abruption is suggested by several factors in this scenario, including the woman’s age (which increases the risk), high parity, the onset of clinical shock, and most notably, a tender and hard uterus upon examination. Given the gestational age, an ectopic pregnancy or miscarriage is unlikely, and while placenta previa is a common cause of antepartum hemorrhage, it typically presents with painless vaginal bleeding.

Placental Abruption: Causes, Symptoms, and Risk Factors

Placental abruption is a condition that occurs when the placenta separates from the uterine wall, leading to maternal bleeding into the space between the placenta and the uterus. Although the exact cause of placental abruption is unknown, certain factors have been associated with the condition, including proteinuric hypertension, cocaine use, multiparity, maternal trauma, and increasing maternal age. Placental abruption is relatively rare, occurring in approximately 1 out of 200 pregnancies.

The clinical features of placental abruption include shock that is disproportionate to the visible blood loss, constant pain, a tender and tense uterus, a normal lie and presentation, and absent or distressed fetal heart sounds. Coagulation problems may also occur, and it is important to be aware of the potential for pre-eclampsia, disseminated intravascular coagulation (DIC), and anuria.

In summary, placental abruption is a serious condition that can have significant consequences for both the mother and the fetus. Understanding the risk factors and symptoms of placental abruption is important for early detection and prompt treatment.

Primary amenorrhoea occurs when a girl has not started menstruating by the age of 15, despite having normal secondary sexual characteristics like breast development. In girls with no secondary sexual characteristics, primary amenorrhoea is defined as the absence of menstruation by the age of 13. Possible causes of primary amenorrhoea include hypothyroidism and imperforate hymen, but not endometriosis, which typically causes heavy and/or painful periods. While delayed menarche can occur spontaneously before the age of 18, this girl’s symptoms are not within the normal range of variation. Malnutrition or extreme exercise are more likely to cause primary amenorrhoea than obesity-induced amenorrhoea, which typically results in secondary amenorrhoea where periods stop for 6 months or more after menarche has occurred.

Understanding Amenorrhoea: Causes, Investigations, and Management

Amenorrhoea is a condition characterized by the absence of menstrual periods. It can be classified into two types: primary and secondary. Primary amenorrhoea occurs when menstruation fails to start by the age of 15 in girls with normal secondary sexual characteristics or by the age of 13 in girls with no secondary sexual characteristics. On the other hand, secondary amenorrhoea is the cessation of menstruation for 3-6 months in women with previously normal and regular menses or 6-12 months in women with previous oligomenorrhoea.

The causes of amenorrhoea vary depending on the type. Primary amenorrhoea may be caused by gonadal dysgenesis, testicular feminization, congenital malformations of the genital tract, functional hypothalamic amenorrhoea, congenital adrenal hyperplasia, imperforate hymen, hypothalamic amenorrhoea, polycystic ovarian syndrome, hyperprolactinemia, premature ovarian failure, and thyrotoxicosis. Meanwhile, secondary amenorrhoea may be caused by stress, excessive exercise, PCOS, Sheehan’s syndrome, Asherman’s syndrome, and other underlying medical conditions.

To diagnose amenorrhoea, initial investigations may include pregnancy tests, full blood count, urea & electrolytes, coeliac screen, thyroid function tests, gonadotrophins, prolactin, and androgen levels. Management of amenorrhoea involves treating the underlying cause. For primary amenorrhoea, it is important to investigate and treat any underlying cause. For secondary amenorrhoea, it is important to exclude pregnancy, lactation, and menopause and treat the underlying cause accordingly. Women with primary ovarian insufficiency due to gonadal dysgenesis may benefit from hormone replacement therapy to prevent osteoporosis and other complications.

In conclusion, amenorrhoea is a condition that requires proper diagnosis and management. Understanding the causes and appropriate investigations can help in providing the necessary treatment and care for women experiencing this condition.

Upper right quadrant pain can be caused by various conditions, but in this case, the woman is suffering from pelvic inflammatory disease, which is often associated with Fitz-Hugh-Curtis syndrome (adhesions of liver to peritoneum).

It is important to note that cholecystitis, pulmonary embolisms, pleurisy, and viral hepatitis do not typically present with symptoms such as dyspareunia, dysuria, or vaginal discharge.

Pelvic inflammatory disease (PID) is a condition where the female pelvic organs, including the uterus, fallopian tubes, ovaries, and surrounding peritoneum, become infected and inflamed. It is typically caused by an infection that spreads from the endocervix. The most common causative organism is Chlamydia trachomatis, followed by Neisseria gonorrhoeae, Mycoplasma genitalium, and Mycoplasma hominis. Symptoms of PID include lower abdominal pain, fever, dyspareunia, dysuria, menstrual irregularities, vaginal or cervical discharge, and cervical excitation.

To diagnose PID, a pregnancy test should be done to rule out an ectopic pregnancy, and a high vaginal swab should be taken to screen for Chlamydia and gonorrhoeae. However, these tests may often be negative, so consensus guidelines recommend having a low threshold for treatment due to the potential complications of untreated PID. Management typically involves oral ofloxacin and oral metronidazole or intramuscular ceftriaxone, oral doxycycline, and oral metronidazole. In mild cases of PID, intrauterine contraceptive devices may be left in, but the evidence is limited, and removal of the IUD may be associated with better short-term clinical outcomes according to recent guidelines.

Complications of PID include perihepatitis (Fitz-Hugh Curtis Syndrome), which occurs in around 10% of cases and is characterized by right upper quadrant pain that may be confused with cholecystitis, infertility (with a risk as high as 10-20% after a single episode), chronic pelvic pain, and ectopic pregnancy.

The most probable nerve root to be affected in shingles, which causes a rash to follow straight lines along dermatomes without crossing the midline, is T4-T6. This is because the breast is innervated by intercostal nerve branches from these nerve roots.

The breast is situated on a layer of pectoral fascia and is surrounded by the pectoralis major, serratus anterior, and external oblique muscles. The nerve supply to the breast comes from branches of intercostal nerves from T4-T6, while the arterial supply comes from the internal mammary (thoracic) artery, external mammary artery (laterally), anterior intercostal arteries, and thoraco-acromial artery. The breast’s venous drainage is through a superficial venous plexus to subclavian, axillary, and intercostal veins. Lymphatic drainage occurs through the axillary nodes, internal mammary chain, and other lymphatic sites such as deep cervical and supraclavicular fossa (later in disease).

The preparation for lactation involves the hormones oestrogen, progesterone, and human placental lactogen. Oestrogen promotes duct development in high concentrations, while high levels of progesterone stimulate the formation of lobules. Human placental lactogen prepares the mammary glands for lactation. The two hormones involved in stimulating lactation are prolactin and oxytocin. Prolactin causes milk secretion, while oxytocin causes contraction of the myoepithelial cells surrounding the mammary alveoli to result in milk ejection from the breast. Suckling of the baby stimulates the mechanoreceptors in the nipple, resulting in the release of both prolactin and oxytocin from the pituitary gland (anterior and posterior parts respectively).

Miscarriage is not caused by a single factor, but rather by a combination of risk factors. Women over the age of 35 and men over the age of 40 are at a significantly higher risk of experiencing a miscarriage. It is important to note that activities such as exercise, emotional stress, consuming spicy foods, and engaging in sexual intercourse do not increase the risk of miscarriage.

Miscarriage: Understanding the Epidemiology

Miscarriage, also known as spontaneous abortion, refers to the natural expulsion of the products of conception before the 24th week of pregnancy. It is a common occurrence, with approximately 15-20% of diagnosed pregnancies ending in miscarriage during the early stages. To avoid any confusion, the term miscarriage is often used instead of abortion.

Studies show that up to 50% of conceptions fail to develop into a blastocyst within 14 days. This highlights the importance of early detection and monitoring during pregnancy. Additionally, recurrent spontaneous miscarriage affects approximately 1% of women, which can be a distressing and emotionally challenging experience.

Understanding the epidemiology of miscarriage is crucial in providing appropriate care and support for women who experience this loss. With proper medical attention and emotional support, women can navigate through this difficult time and move forward with hope and healing.

During pregnancy, the main contributor to the increased cardiac output is the increased stroke volume, which is caused by the activation of the renin-angiotensin system and the subsequent increase in plasma volume. Although the heart rate also increases slightly, it is not as significant as the increase in stroke volume. Therefore, the major contributor to the increased cardiac output is the stroke volume.

The statements ‘decreased heart rate’ and ‘increased peripheral resistance’ are incorrect. In fact, peripheral resistance decreases due to progesterone, which contributes to the normal decrease in blood pressure during pregnancy. Peripheral resistance is more concerned with blood pressure.

Pregnancy also causes various physiological changes, including increased uterine size, cervical ectropion, reduced cervical collagen, and increased vaginal discharge. Cardiovascular and haemodynamic changes include increased plasma volume, anaemia, increased white cell count, platelets, ESR, cholesterol, and fibrinogen, as well as decreased albumin, urea, and creatinine. Progesterone-related effects, such as muscle relaxation, can cause decreased blood pressure, constipation, ureteral dilation, bladder relaxation, biliary stasis, and increased tidal volume.

During pregnancy, a woman’s body undergoes various physiological changes. The cardiovascular system experiences an increase in stroke volume, heart rate, and cardiac output, while systolic blood pressure remains unchanged and diastolic blood pressure decreases in the first and second trimesters before returning to normal levels by term. The enlarged uterus may cause issues with venous return, leading to ankle swelling, supine hypotension, and varicose veins.

The respiratory system sees an increase in pulmonary ventilation and tidal volume, with oxygen requirements only increasing by 20%. This can lead to a sense of dyspnea due to over-breathing and a fall in pCO2. The basal metabolic rate also increases, potentially due to increased thyroxine and adrenocortical hormones.

Maternal blood volume increases by 30%, with red blood cells increasing by 20% and plasma increasing by 50%, leading to a decrease in hemoglobin levels. Coagulant activity increases slightly, while fibrinolytic activity decreases. Platelet count falls, and white blood cell count and erythrocyte sedimentation rate rise.

The urinary system experiences an increase in blood flow and glomerular filtration rate, with elevated sex steroid levels leading to increased salt and water reabsorption and urinary protein losses. Trace glycosuria may also occur.

Calcium requirements increase during pregnancy, with gut absorption increasing substantially due to increased 1,25 dihydroxy vitamin D. Serum levels of calcium and phosphate may fall, but ionized calcium levels remain stable. The liver experiences an increase in alkaline phosphatase and a decrease in albumin levels.

The uterus undergoes significant changes, increasing in weight from 100g to 1100g and transitioning from hyperplasia to hypertrophy. Cervical ectropion and discharge may increase, and Braxton-Hicks contractions may occur in late pregnancy. Retroversion may lead to retention in the first trimester but usually self-corrects.

The peritoneum gives rise to the tunica vaginalis, which produces the fluid that occupies the hydrocele space.

Anatomy of the Scrotum and Testes

The scrotum is composed of skin and dartos fascia, with an arterial supply from the anterior and posterior scrotal arteries. It is also the site of lymphatic drainage to the inguinal lymph nodes. The testes are surrounded by the tunica vaginalis, a closed peritoneal sac, with the parietal layer adjacent to the internal spermatic fascia. The testicular arteries arise from the aorta, just below the renal arteries, and the pampiniform plexus drains into the testicular veins. The left testicular vein drains into the left renal vein, while the right testicular vein drains into the inferior vena cava. Lymphatic drainage occurs to the para-aortic nodes.

The spermatic cord is formed by the vas deferens and is covered by the internal spermatic fascia, cremasteric fascia, and external spermatic fascia. The cord contains the vas deferens, testicular artery, artery of vas deferens, cremasteric artery, pampiniform plexus, sympathetic nerve fibers, genital branch of the genitofemoral nerve, and lymphatic vessels. The vas deferens transmits sperm and accessory gland secretions, while the testicular artery supplies the testis and epididymis. The cremasteric artery arises from the inferior epigastric artery, and the pampiniform plexus is a venous plexus that drains into the right or left testicular vein. The sympathetic nerve fibers lie on the arteries, while the parasympathetic fibers lie on the vas. The genital branch of the genitofemoral nerve supplies the cremaster. Lymphatic vessels drain to lumbar and para-aortic nodes.

During the early stages of pregnancy, the corpus luteum is stimulated to secrete progesterone by hCG, which is produced by the syncytiotrophoblast. Pregnancy tests commonly measure hCG levels in urine. This hormone is crucial for maintaining the pregnancy until the placenta is fully developed. The trophoblast is composed of two layers: the cytotrophoblast and the syncytiotrophoblast. The hypoblast is a type of tissue that forms from the inner cell mass, while the epiblast gives rise to the three primary germ layers and extraembryonic mesoderm.

Endocrine Changes During Pregnancy

During pregnancy, there are several physiological changes that occur in the body, including endocrine changes. Progesterone, which is produced by the fallopian tubes during the first two weeks of pregnancy, stimulates the secretion of nutrients required by the zygote/blastocyst. At six weeks, the placenta takes over the production of progesterone, which inhibits uterine contractions by decreasing sensitivity to oxytocin and inhibiting the production of prostaglandins. Progesterone also stimulates the development of lobules and alveoli.

Oestrogen, specifically oestriol, is another major hormone produced during pregnancy. It stimulates the growth of the myometrium and the ductal system of the breasts. Prolactin, which increases during pregnancy, initiates and maintains milk secretion of the mammary gland. It is essential for the expression of the mammotropic effects of oestrogen and progesterone. However, oestrogen and progesterone directly antagonize the stimulating effects of prolactin on milk synthesis.

Human chorionic gonadotropin (hCG) is secreted by the syncitiotrophoblast and can be detected within nine days of pregnancy. It mimics LH, rescuing the corpus luteum from degenerating and ensuring early oestrogen and progesterone secretion. It also stimulates the production of relaxin and may inhibit contractions induced by oxytocin. Other hormones produced during pregnancy include relaxin, which suppresses myometrial contractions and relaxes the pelvic ligaments and pubic symphysis, and human placental lactogen (hPL), which has lactogenic actions and enhances protein metabolism while antagonizing insulin.

The most probable cause of the woman’s pain during defecation is bleeding in either the bowel or the pouch of Douglas. Since the only given option is the latter, it is the correct answer. Bleeding into the ovaries can result in ‘chocolate cysts’ that can be observed during laparoscopy. None of the other options mentioned provide anatomical landmarks that could lead to bleeding in the spaces and pain during defecation.

Endometriosis is a condition where endometrial tissue grows outside of the uterus, affecting around 10% of women of reproductive age. Symptoms include chronic pelvic pain, painful periods, pain during sex, and subfertility. Diagnosis is made through laparoscopy, and treatment depends on the severity of symptoms. First-line treatments include NSAIDs and hormonal treatments such as the combined oral contraceptive pill or progestogens. If these do not improve symptoms or fertility is a priority, referral to secondary care may be necessary. Treatment options in secondary care include GnRH analogues and surgery, with laparoscopic excision or ablation of endometriosis plus adhesiolysis recommended for women trying to conceive. Ovarian cystectomy may also be necessary for endometriomas.

The proliferative phase is characterized by the thickening of the endometrium due to the presence of oestrogen secreted by the mature follicle.

As oestrogen levels rise during this phase, the endometrium undergoes proliferation and thickening. Tubular glands extend and spiral arteries form, leading to increased vascularity. Additionally, oestrogen stimulates progesterone receptors on endometrial cells.

Phases of the Menstrual Cycle

The menstrual cycle is a complex process that can be divided into four phases: menstruation, follicular phase, ovulation, and luteal phase. During the follicular phase, a number of follicles develop in the ovaries, with one follicle becoming dominant around the mid-follicular phase. At the same time, the endometrium undergoes proliferation. This phase is characterized by a rise in follicle-stimulating hormone (FSH), which results in the development of follicles that secrete oestradiol. When the egg has matured, it secretes enough oestradiol to trigger the acute release of luteinizing hormone (LH), which leads to ovulation.

During the luteal phase, the corpus luteum secretes progesterone, which causes the endometrium to change to a secretory lining. If fertilization does not occur, the corpus luteum will degenerate, and progesterone levels will fall. Oestradiol levels also rise again during the luteal phase. Cervical mucus thickens and forms a plug across the external os following menstruation. Just prior to ovulation, the mucus becomes clear, acellular, low viscosity, and stretchy. Under the influence of progesterone, it becomes thick, scant, and tacky. Basal body temperature falls prior to ovulation due to the influence of oestradiol and rises following ovulation in response to higher progesterone levels. Understanding the phases of the menstrual cycle is important for women’s health and fertility.

A classic characteristic of invasive lobular carcinoma is the possibility of metastasis to the opposite breast.

Understanding Lobular Carcinoma of the Breast

Lobular carcinoma of the breast is a less common type of breast cancer that presents differently from ductal carcinoma. The mass is usually more diffuse and less obvious on imaging tests like ultrasound and mammography, which can result in inadequate treatment if the disease is understaged. For women with invasive lobular carcinoma, an MRI scan of the breast is usually recommended before breast conserving surgery is performed to ensure the safest approach.

Lobular carcinomas are also more likely to be multifocal and metastasize to the opposite breast. In some cases, lobular carcinoma in situ may be diagnosed incidentally on core biopsies. Unlike ductal carcinoma in situ, lobular carcinoma in situ is less strongly associated with foci of invasion and is usually managed through close monitoring. Understanding the differences between lobular and ductal carcinoma can help healthcare professionals provide the best possible care for patients with breast cancer.

Primary amenorrhoea is when a girl has not started menstruating by the age of 15, despite having normal secondary sexual characteristics, or by the age of 13 with no secondary sexual characteristics such as breast development or pubic hair growth. If a girl has not developed any secondary sexual characteristics by the age of 13, this could indicate primary amenorrhoea and should be investigated further with blood tests to rule out any hormonal issues such as Turner’s syndrome. However, if a girl is 8 years old and has not yet developed any secondary sexual characteristics, this is not a concern for primary amenorrhoea but may indicate precocious puberty, which requires treatment. On the other hand, if a 10-year-old girl has not yet developed any secondary sexual characteristics, this is a normal presentation and does not require investigation. Finally, if a 12-year-old girl has normal breast and pubic hair growth, she would need to have three more years of amenorrhoea before it is considered pathological.

Understanding Amenorrhoea: Causes, Investigations, and Management

Amenorrhoea is a condition characterized by the absence of menstrual periods. It can be classified into two types: primary and secondary. Primary amenorrhoea occurs when menstruation fails to start by the age of 15 in girls with normal secondary sexual characteristics or by the age of 13 in girls with no secondary sexual characteristics. On the other hand, secondary amenorrhoea is the cessation of menstruation for 3-6 months in women with previously normal and regular menses or 6-12 months in women with previous oligomenorrhoea.

The causes of amenorrhoea vary depending on the type. Primary amenorrhoea may be caused by gonadal dysgenesis, testicular feminization, congenital malformations of the genital tract, functional hypothalamic amenorrhoea, congenital adrenal hyperplasia, imperforate hymen, hypothalamic amenorrhoea, polycystic ovarian syndrome, hyperprolactinemia, premature ovarian failure, and thyrotoxicosis. Meanwhile, secondary amenorrhoea may be caused by stress, excessive exercise, PCOS, Sheehan’s syndrome, Asherman’s syndrome, and other underlying medical conditions.

To diagnose amenorrhoea, initial investigations may include pregnancy tests, full blood count, urea & electrolytes, coeliac screen, thyroid function tests, gonadotrophins, prolactin, and androgen levels. Management of amenorrhoea involves treating the underlying cause. For primary amenorrhoea, it is important to investigate and treat any underlying cause. For secondary amenorrhoea, it is important to exclude pregnancy, lactation, and menopause and treat the underlying cause accordingly. Women with primary ovarian insufficiency due to gonadal dysgenesis may benefit from hormone replacement therapy to prevent osteoporosis and other complications.

In conclusion, amenorrhoea is a condition that requires proper diagnosis and management. Understanding the causes and appropriate investigations can help in providing the necessary treatment and care for women experiencing this condition.

Hyperemesis gravidarum is a severe form of nausea and vomiting that affects around 1% of pregnancies. It is usually experienced between 8 and 12 weeks of pregnancy but can persist up to 20 weeks. The condition is thought to be related to raised beta hCG levels and is more common in women who are obese, nulliparous, or have multiple pregnancies, trophoblastic disease, or hyperthyroidism. Smoking is associated with a decreased incidence of hyperemesis.

The Royal College of Obstetricians and Gynaecologists recommend that a woman must have a 5% pre-pregnancy weight loss, dehydration, and electrolyte imbalance before a diagnosis of hyperemesis gravidarum can be made. Validated scoring systems such as the Pregnancy-Unique Quantification of Emesis (PUQE) score can be used to classify the severity of NVP.

Management of hyperemesis gravidarum involves using antihistamines as a first-line treatment, with oral cyclizine or oral promethazine being recommended by Clinical Knowledge Summaries. Oral prochlorperazine is an alternative, while ondansetron and metoclopramide may be used as second-line treatments. Ginger and P6 (wrist) acupressure can be tried, but there is little evidence of benefit. Admission may be needed for IV hydration.

Complications of hyperemesis gravidarum can include Wernicke’s encephalopathy, Mallory-Weiss tear, central pontine myelinolysis, acute tubular necrosis, and fetal growth restriction, pre-term birth, and cleft lip/palate (if ondansetron is used during the first trimester). The NICE Clinical Knowledge Summaries recommend considering admission if a woman is unable to keep down liquids or oral antiemetics, has ketonuria and/or weight loss (greater than 5% of body weight), or has a confirmed or suspected comorbidity that may be adversely affected by nausea and vomiting.

Hypergonadotropic hypogonadism occurs when the gonads fail to respond to gonadotropins produced by the anterior pituitary gland. This is commonly seen in Turner’s syndrome, where gonadal dysgenesis leads to low sex steroid levels despite elevated levels of LH and FSH. On the other hand, hypogonadotropic hypogonadism can be caused by Kallmann syndrome, Sheehan’s syndrome, and anorexia nervosa. In Asherman’s syndrome, intrauterine adhesions develop, often due to surgery.

Understanding Infertility: Initial Investigations and Key Counselling Points

Infertility is a common issue that affects approximately 1 in 7 couples. However, it is important to note that around 84% of couples who have regular sex will conceive within 1 year, and 92% within 2 years. The causes of infertility can vary, with male factor accounting for 30%, unexplained causes accounting for 20%, ovulation failure accounting for 20%, tubal damage accounting for 15%, and other causes accounting for the remaining 15%.

To determine the cause of infertility, basic investigations are typically conducted. These include a semen analysis and a serum progesterone test, which is done 7 days prior to the expected next period. The interpretation of the serum progesterone level is as follows: if the level is less than 16 nmol/l, it should be repeated and if it consistently remains low, referral to a specialist is necessary. If the level is between 16-30 nmol/l, it should be repeated, and if it is greater than 30 nmol/l, it indicates ovulation.

In addition to these investigations, there are key counselling points that should be addressed. These include advising the patient to take folic acid, aiming for a BMI between 20-25, and having regular sexual intercourse every 2 to 3 days. Patients should also be advised to quit smoking and limit alcohol consumption.

By understanding the initial investigations and key counselling points for infertility, healthcare professionals can provide their patients with the necessary information and support to help them conceive.

The main cause of menopausal symptoms is low levels of oestrogen, which is why hormone replacement therapy (HRT) aims to alleviate these symptoms by supplementing oestrogen. However, oestrogen can lead to thickening of the endometrium, which increases the risk of neoplasia. To counteract this risk, progesterone is also included in HRT to prevent endometrial thickening and any associated malignancy.

Therefore, any statement suggesting that progesterone is used for symptomatic relief, that oestrogen is protective, or that progesterone and oestrogen work together in a synergistic manner is incorrect.

Symptoms of Menopause

Menopause is a natural biological process that marks the end of a woman’s reproductive years. It is characterized by a decrease in the levels of female hormones, particularly oestrogen, which can lead to a range of symptoms. One of the most common symptoms is a change in periods, including changes in the length of menstrual cycles and dysfunctional uterine bleeding.

Around 80% of women experience vasomotor symptoms, which can occur daily and last for up to five years. These symptoms include hot flushes and night sweats. Urogenital changes are also common, affecting around 35% of women. These changes can include vaginal dryness and atrophy, as well as urinary frequency.

In addition to physical symptoms, menopause can also have psychological effects. Approximately 10% of women experience anxiety and depression during this time, as well as short-term memory impairment. It is important to note that menopause can also have longer-term complications, such as an increased risk of osteoporosis and ischaemic heart disease.

Hyperemesis gravidarum is a severe form of nausea and vomiting that affects around 1% of pregnancies. It is usually experienced between 8 and 12 weeks of pregnancy but can persist up to 20 weeks. The condition is thought to be related to raised beta hCG levels and is more common in women who are obese, nulliparous, or have multiple pregnancies, trophoblastic disease, or hyperthyroidism. Smoking is associated with a decreased incidence of hyperemesis.

The Royal College of Obstetricians and Gynaecologists recommend that a woman must have a 5% pre-pregnancy weight loss, dehydration, and electrolyte imbalance before a diagnosis of hyperemesis gravidarum can be made. Validated scoring systems such as the Pregnancy-Unique Quantification of Emesis (PUQE) score can be used to classify the severity of NVP.

Management of hyperemesis gravidarum involves using antihistamines as a first-line treatment, with oral cyclizine or oral promethazine being recommended by Clinical Knowledge Summaries. Oral prochlorperazine is an alternative, while ondansetron and metoclopramide may be used as second-line treatments. Ginger and P6 (wrist) acupressure can be tried, but there is little evidence of benefit. Admission may be needed for IV hydration.

Complications of hyperemesis gravidarum can include Wernicke’s encephalopathy, Mallory-Weiss tear, central pontine myelinolysis, acute tubular necrosis, and fetal growth restriction, pre-term birth, and cleft lip/palate (if ondansetron is used during the first trimester). The NICE Clinical Knowledge Summaries recommend considering admission if a woman is unable to keep down liquids or oral antiemetics, has ketonuria and/or weight loss (greater than 5% of body weight), or has a confirmed or suspected comorbidity that may be adversely affected by nausea and vomiting.

The correct answer is the cardinal ligament, which connects the cervix to the lateral pelvic wall. Pelvic surgery can damage this ligament, which may lead to cervical prolapse in severe cases.

The broad ligament surrounds the fallopian tubes and ovaries, along with their respective neurovascular structures. However, it does not attach the cervix to the lateral pelvic wall.

The pubocervical ligament anchors the cervix to the pubic symphysis. In severe cases, damage to this ligament may contribute to vaginal prolapse.

The round ligament of the uterus maintains the anteverted position of the uterus. During pregnancy, stretching of the round ligament may cause round ligament pain.

The uterosacral ligament anchors the uterus to the sacrum posteriorly, helping to maintain normal pelvic anatomy and prevent the descent of pelvic organs into the vaginal vault.

Pelvic Ligaments and their Connections

Pelvic ligaments are structures that connect various organs within the female reproductive system to the pelvic wall. These ligaments play a crucial role in maintaining the position and stability of these organs. There are several types of pelvic ligaments, each with its own unique function and connection.

The broad ligament connects the uterus, fallopian tubes, and ovaries to the pelvic wall, specifically the ovaries. The round ligament connects the uterine fundus to the labia majora, but does not connect to any other structures. The cardinal ligament connects the cervix to the lateral pelvic wall and is responsible for supporting the uterine vessels. The suspensory ligament of the ovaries connects the ovaries to the lateral pelvic wall and supports the ovarian vessels. The ovarian ligament connects the ovaries to the uterus, but does not connect to any other structures. Finally, the uterosacral ligament connects the cervix and posterior vaginal dome to the sacrum, but does not connect to any other structures.

Overall, pelvic ligaments are essential for maintaining the proper position and function of the female reproductive organs. Understanding the connections between these ligaments and the structures they support is crucial for diagnosing and treating any issues that may arise.

Hyperemesis gravidarum is a condition that causes severe nausea and vomiting during pregnancy, leading to weight loss. Abdominal pain is not a common symptom and may indicate another gastrointestinal disorder.

Hyperemesis gravidarum is a severe form of nausea and vomiting that affects around 1% of pregnancies. It is usually experienced between 8 and 12 weeks of pregnancy but can persist up to 20 weeks. The condition is thought to be related to raised beta hCG levels and is more common in women who are obese, nulliparous, or have multiple pregnancies, trophoblastic disease, or hyperthyroidism. Smoking is associated with a decreased incidence of hyperemesis.

The Royal College of Obstetricians and Gynaecologists recommend that a woman must have a 5% pre-pregnancy weight loss, dehydration, and electrolyte imbalance before a diagnosis of hyperemesis gravidarum can be made. Validated scoring systems such as the Pregnancy-Unique Quantification of Emesis (PUQE) score can be used to classify the severity of NVP.

Management of hyperemesis gravidarum involves using antihistamines as a first-line treatment, with oral cyclizine or oral promethazine being recommended by Clinical Knowledge Summaries. Oral prochlorperazine is an alternative, while ondansetron and metoclopramide may be used as second-line treatments. Ginger and P6 (wrist) acupressure can be tried, but there is little evidence of benefit. Admission may be needed for IV hydration.

Complications of hyperemesis gravidarum can include Wernicke’s encephalopathy, Mallory-Weiss tear, central pontine myelinolysis, acute tubular necrosis, and fetal growth restriction, pre-term birth, and cleft lip/palate (if ondansetron is used during the first trimester). The NICE Clinical Knowledge Summaries recommend considering admission if a woman is unable to keep down liquids or oral antiemetics, has ketonuria and/or weight loss (greater than 5% of body weight), or has a confirmed or suspected comorbidity that may be adversely affected by nausea and vomiting.

Pelvic inflammatory disease is most commonly caused by chlamydia and gonorrhoeae, with gonorrhoeae being the likely cause in this patient since they do not have chlamydia. While HIV does not directly cause pelvic inflammatory disease, it can increase the risk of contracting sexually transmitted infections. Syphilis follows its own distinct clinical course and does not cause pelvic inflammatory disease, while herpes typically presents with painful genital blisters but does not cause pelvic inflammatory disease.

Pelvic inflammatory disease (PID) is a condition where the female pelvic organs, including the uterus, fallopian tubes, ovaries, and surrounding peritoneum, become infected and inflamed. It is typically caused by an infection that spreads from the endocervix. The most common causative organism is Chlamydia trachomatis, followed by Neisseria gonorrhoeae, Mycoplasma genitalium, and Mycoplasma hominis. Symptoms of PID include lower abdominal pain, fever, dyspareunia, dysuria, menstrual irregularities, vaginal or cervical discharge, and cervical excitation.

To diagnose PID, a pregnancy test should be done to rule out an ectopic pregnancy, and a high vaginal swab should be taken to screen for Chlamydia and gonorrhoeae. However, these tests may often be negative, so consensus guidelines recommend having a low threshold for treatment due to the potential complications of untreated PID. Management typically involves oral ofloxacin and oral metronidazole or intramuscular ceftriaxone, oral doxycycline, and oral metronidazole. In mild cases of PID, intrauterine contraceptive devices may be left in, but the evidence is limited, and removal of the IUD may be associated with better short-term clinical outcomes according to recent guidelines.

Complications of PID include perihepatitis (Fitz-Hugh Curtis Syndrome), which occurs in around 10% of cases and is characterized by right upper quadrant pain that may be confused with cholecystitis, infertility (with a risk as high as 10-20% after a single episode), chronic pelvic pain, and ectopic pregnancy.

During menopause, there is a decrease in oestrogen levels due to the ovaries responding poorly to FSH and LH. This leads to an increase in both FSH and LH levels as there is less negative feedback from oestrogen. Therefore, any response indicating high levels of one hormone and low levels of the other is incorrect.

Understanding Menopause and Contraception

Menopause is a natural biological process that marks the end of a woman’s reproductive years. It typically occurs when a woman reaches the age of 51 in the UK. However, prior to menopause, women may experience a period known as the climacteric. During this time, ovarian function starts to decline, and women may experience symptoms such as hot flashes, mood swings, and vaginal dryness.

It is important for women to understand that they can still become pregnant during the climacteric period. Therefore, it is recommended to use effective contraception until a certain period of time has passed. Women over the age of 50 should use contraception for 12 months after their last period, while women under the age of 50 should use contraception for 24 months after their last period. By understanding menopause and the importance of contraception during the climacteric period, women can make informed decisions about their reproductive health.

When it comes to fibroids and difficulty conceiving, submucosal fibroids are the most likely culprit. These fibroids are located in the uterine cavity and can interfere with the implantation of an embryo. Intramural and subserosal fibroids are less likely to cause fertility issues, but they can cause symptoms such as increased urinary frequency and constipation due to their size and location. It’s important to note that fibroids are typically found within the uterus and not outside of it.

Understanding Uterine Fibroids

Uterine fibroids are non-cancerous growths that develop in the uterus. They are more common in black women and are believed to occur in around 20% of white women in their later reproductive years. Fibroids are usually asymptomatic, but they can cause menorrhagia, which can lead to iron-deficiency anaemia. Other symptoms include lower abdominal pain, bloating, and urinary symptoms. Fibroids may also cause subfertility, but this is rare.

Diagnosis is usually done through transvaginal ultrasound. Asymptomatic fibroids do not require treatment, but periodic monitoring is necessary. For menorrhagia, treatment options include the levonorgestrel intrauterine system, NSAIDs, tranexamic acid, oral progestogen, and injectable progestogen. Medical treatment to shrink or remove fibroids includes GnRH agonists and ulipristal acetate, while surgical options include myomectomy, hysteroscopic endometrial ablation, hysterectomy, and uterine artery embolization.

Fibroids generally regress after menopause, and complications such as subfertility and iron-deficiency anaemia have been mentioned previously. Another complication is red degeneration, which is haemorrhage into the tumour and commonly occurs during pregnancy. Understanding uterine fibroids is important for women’s health, and seeking medical attention is necessary if symptoms arise.

Smoking is a protective factor against only one type of cancer, which is endometrial cancer (3), as found by a meta-analysis. However, smoking is a risk factor for all the other types of cancer mentioned.

For bladder cancer (1), it is suggested that the aromatic amines found in cigarettes are a known carcinogen of the bladder, thus contributing to the increased risk of bladder cancer with smoking.

Although smoking is a well-established co-factor for the development of cervical cancer (2), the mechanism by which smoking increases the risk is not known, although there are two theories.

Smoking has been found to cause numerous DNA changes in laryngeal cancer (4), including TP53 gene mutations.

Smoking is also theorized to cause renal cell cancer (5) as cigarette smoke induces oxidative stress and injury in the kidney, and free radicals in cigarettes can cause DNA damage that may lead to the development of cancer.

Endometrial cancer is a type of cancer that is commonly found in women who have gone through menopause, but it can also occur in around 25% of cases before menopause. The prognosis for this type of cancer is usually good due to early detection. There are several risk factors associated with endometrial cancer, including obesity, nulliparity, early menarche, late menopause, unopposed estrogen, diabetes mellitus, tamoxifen, polycystic ovarian syndrome, and hereditary non-polyposis colorectal carcinoma. Symptoms of endometrial cancer include postmenopausal bleeding, which is usually slight and intermittent at first before becoming heavier, and changes in intermenstrual bleeding for premenopausal women. Pain is not common and typically signifies extensive disease, while vaginal discharge is unusual.

When investigating endometrial cancer, women who are 55 years or older and present with postmenopausal bleeding should be referred using the suspected cancer pathway. The first-line investigation is trans-vaginal ultrasound, which has a high negative predictive value for a normal endometrial thickness of less than 4 mm. Hysteroscopy with endometrial biopsy is also commonly used for diagnosis. Treatment for localized disease typically involves total abdominal hysterectomy with bilateral salpingo-oophorectomy, while patients with high-risk disease may require postoperative radiotherapy. Progestogen therapy may be used in frail elderly women who are not considered suitable for surgery. It is important to note that the combined oral contraceptive pill and smoking are protective against endometrial cancer.

Placental insufficiency is linked to asymmetrical growth restriction in small for gestational age babies.

When a fetus or infant experiences growth restriction, it can be categorized as either symmetrical or asymmetrical.

Asymmetrical growth restriction occurs when the weight or abdominal circumference is lower than the head circumference. This is typically caused by inadequate nutrition from the placenta in the later stages of pregnancy, with brain growth being prioritized over liver glycogen and skin fat. Placental insufficiency is often associated with this type of growth restriction.

Symmetrical growth restriction, on the other hand, is characterized by a reduction in head circumference that is equal to other measurements. This type of growth restriction is usually caused by factors such as congenital infection, fetal chromosomal disorder (such as Down syndrome), underlying maternal hypothyroidism, or malnutrition. It suggests a prolonged period of poor intrauterine growth that begins early in pregnancy.

In reality, it is often difficult to distinguish between asymmetrical and symmetrical growth restriction.

Small for Gestational Age (SGA) is a statistical definition used to describe babies who are smaller than expected for their gestational age. Although there is no universally agreed percentile, the 10th percentile is often used, meaning that 10% of normal babies will be below this threshold. SGA can be determined either antenatally or postnatally. There are two types of SGA: symmetrical and asymmetrical. Symmetrical SGA occurs when the fetal head circumference and abdominal circumference are equally small, while asymmetrical SGA occurs when the abdominal circumference slows relative to the increase in head circumference.

There are various causes of SGA, including incorrect dating, constitutionally small (normal) babies, and abnormal fetuses. Symmetrical SGA is more common and can be caused by idiopathic factors, race, sex, placental insufficiency, pre-eclampsia, chromosomal and congenital abnormalities, toxins such as smoking and heroin, and infections such as CMV, parvovirus, rubella, syphilis, and toxoplasmosis. Asymmetrical SGA is less common and can be caused by toxins such as alcohol, cigarettes, and heroin, chromosomal and congenital abnormalities, and infections.

The management of SGA depends on the type and cause. For symmetrical SGA, most cases represent the lower limits of the normal range and require fortnightly ultrasound growth assessments to demonstrate normal growth rates. Pathological causes should be ruled out by checking maternal blood for infections and searching the fetus carefully with ultrasound for markers of chromosomal abnormality. Asymmetrical SGA also requires fortnightly ultrasound growth assessments, as well as biophysical profiles and Doppler waveforms from umbilical circulation to look for absent end-diastolic flow. If results are sub-optimal, delivery may be considered.

Miscarriage is the loss of a pregnancy before the 20th week. It is a common occurrence, with about 10-20% of pregnancies ending in miscarriage. In most cases, the cause of miscarriage is unknown, but it can be due to genetic abnormalities, hormonal imbalances, or health conditions such as diabetes or thyroid problems.

There are different types of miscarriage, including complete, incomplete, inevitable, and septic. A complete miscarriage is when all fetal tissue has been passed, bleeding has stopped, the uterus is no longer enlarged, and the cervical os is closed. An incomplete miscarriage is when only some fetal parts have been passed, and the cervical os is usually open. An inevitable miscarriage means that a miscarriage is about to occur, with the fetus still possibly alive but the cervical os open and bleeding usually heavier. A septic miscarriage occurs when the contents of the uterus are infected, causing endometritis. Symptoms include offensive vaginal loss, tender uterus, and in cases of pelvic infection, abdominal pain and peritonism.

Types of Miscarriage

Miscarriage is a common complication that can occur during pregnancy. There are different types of miscarriage, each with its own set of symptoms and characteristics. One type is threatened miscarriage, which is painless vaginal bleeding that occurs before 24 weeks, typically at 6-9 weeks. The bleeding is usually less than menstruation, and the cervical os is closed. This type of miscarriage complicates up to 25% of all pregnancies.

Another type is missed (delayed) miscarriage, which is characterized by a gestational sac that contains a dead fetus before 20 weeks without the symptoms of expulsion. The mother may experience light vaginal bleeding or discharge and the disappearance of pregnancy symptoms, but pain is not usually present. The cervical os is closed, and when the gestational sac is larger than 25 mm and no embryonic or fetal part can be seen, it is sometimes referred to as a blighted ovum or anembryonic pregnancy.

Inevitable miscarriage is another type, which is characterized by heavy bleeding with clots and pain. The cervical os is open in this case. Lastly, incomplete miscarriage occurs when not all products of conception have been expelled. This type of miscarriage is characterized by pain and vaginal bleeding, and the cervical os is open. Understanding the different types of miscarriage can help individuals recognize the symptoms and seek appropriate medical attention.

The patient is exhibiting signs of HELLP syndrome, which is a complication during pregnancy that involves haemolysis, elevated liver enzymes, and low platelets. This condition often occurs alongside pregnancy-induced hypertension or pre-eclampsia. Although the patient is also displaying symptoms of pre-eclampsia such as headache, shoulder tip pain, and nausea, the presence of jaundice indicates that it is HELLP syndrome rather than pre-eclampsia. Pre-eclampsia is a pregnancy disorder that typically involves high blood pressure and damage to another organ system, usually the kidneys in the form of proteinuria. It usually develops after 20 weeks of pregnancy in women who previously had normal blood pressure.

Jaundice During Pregnancy

During pregnancy, jaundice can occur due to various reasons. One of the most common liver diseases during pregnancy is intrahepatic cholestasis of pregnancy, which affects around 1% of pregnancies and is usually seen in the third trimester. Symptoms include itching, especially in the palms and soles, and raised bilirubin levels. Ursodeoxycholic acid is used for symptomatic relief, and women are typically induced at 37 weeks. However, this condition can increase the risk of stillbirth.

Acute fatty liver of pregnancy is a rare complication that can occur in the third trimester or immediately after delivery. Symptoms include abdominal pain, nausea, vomiting, headache, jaundice, and hypoglycemia. ALT levels are typically elevated. Supportive care is the initial management, and delivery is the definitive management once the patient is stabilized.

Gilbert’s and Dubin-Johnson syndrome may also be exacerbated during pregnancy. Additionally, HELLP syndrome, which stands for Haemolysis, Elevated Liver enzymes, Low Platelets, can also cause jaundice during pregnancy. It is important to monitor liver function tests and seek medical attention if any symptoms of jaundice occur during pregnancy.

The primary location for lymphatic drainage of the breast is the ipsilateral axillary nodes. While there have been cases of breast cancer spreading to contralateral axillary nodes, these nodes do not represent the main site of lymphatic drainage for the opposite breast. The parasternal nodes receive some lymphatic drainage, but they are not the primary site for breast drainage. The supraclavicular nodes may occasionally receive drainage from the breast, but this is not significant. The infraclavicular nodes, despite their proximity, do not drain the breast; they instead receive drainage from the forearm and hand.

The breast is situated on a layer of pectoral fascia and is surrounded by the pectoralis major, serratus anterior, and external oblique muscles. The nerve supply to the breast comes from branches of intercostal nerves from T4-T6, while the arterial supply comes from the internal mammary (thoracic) artery, external mammary artery (laterally), anterior intercostal arteries, and thoraco-acromial artery. The breast’s venous drainage is through a superficial venous plexus to subclavian, axillary, and intercostal veins. Lymphatic drainage occurs through the axillary nodes, internal mammary chain, and other lymphatic sites such as deep cervical and supraclavicular fossa (later in disease).

The preparation for lactation involves the hormones oestrogen, progesterone, and human placental lactogen. Oestrogen promotes duct development in high concentrations, while high levels of progesterone stimulate the formation of lobules. Human placental lactogen prepares the mammary glands for lactation. The two hormones involved in stimulating lactation are prolactin and oxytocin. Prolactin causes milk secretion, while oxytocin causes contraction of the myoepithelial cells surrounding the mammary alveoli to result in milk ejection from the breast. Suckling of the baby stimulates the mechanoreceptors in the nipple, resulting in the release of both prolactin and oxytocin from the pituitary gland (anterior and posterior parts respectively).

Electrolyte imbalances commonly observed in hyperemesis gravidarum include hyponatraemia, hypokalaemia, hypochloraemia, and metabolic alkalosis. This is due to excessive vomiting, which can deplete the body of electrolytes and lead to a loss of hydrogen ions, resulting in metabolic alkalosis. Hyperkalaemia and hypermagnesaemia are unlikely to occur, and hypomagnesaemia is more commonly associated with hyperemesis gravidarum. Metabolic acidosis is not typically seen in this condition.

Hyperemesis gravidarum is a severe form of nausea and vomiting that affects around 1% of pregnancies. It is usually experienced between 8 and 12 weeks of pregnancy but can persist up to 20 weeks. The condition is thought to be related to raised beta hCG levels and is more common in women who are obese, nulliparous, or have multiple pregnancies, trophoblastic disease, or hyperthyroidism. Smoking is associated with a decreased incidence of hyperemesis.

The Royal College of Obstetricians and Gynaecologists recommend that a woman must have a 5% pre-pregnancy weight loss, dehydration, and electrolyte imbalance before a diagnosis of hyperemesis gravidarum can be made. Validated scoring systems such as the Pregnancy-Unique Quantification of Emesis (PUQE) score can be used to classify the severity of NVP.

Management of hyperemesis gravidarum involves using antihistamines as a first-line treatment, with oral cyclizine or oral promethazine being recommended by Clinical Knowledge Summaries. Oral prochlorperazine is an alternative, while ondansetron and metoclopramide may be used as second-line treatments. Ginger and P6 (wrist) acupressure can be tried, but there is little evidence of benefit. Admission may be needed for IV hydration.

Complications of hyperemesis gravidarum can include Wernicke’s encephalopathy, Mallory-Weiss tear, central pontine myelinolysis, acute tubular necrosis, and fetal growth restriction, pre-term birth, and cleft lip/palate (if ondansetron is used during the first trimester). The NICE Clinical Knowledge Summaries recommend considering admission if a woman is unable to keep down liquids or oral antiemetics, has ketonuria and/or weight loss (greater than 5% of body weight), or has a confirmed or suspected comorbidity that may be adversely affected by nausea and vomiting.

The most common type of ovulatory disorder is normogonadotropic normoestrogenic anovulation, which is often associated with polycystic ovarian syndrome (PCOS). This condition is characterized by normal levels of gonadotropin and estrogen, but low levels of FSH during the follicular phase can lead to anovulation. It is important to perform a thorough evaluation of both male and female factors when investigating infertility. Hypogonadotropic hypogonadal anovulation, which is characterized by low levels of GnRH or pituitary unresponsiveness to GnRH, resulting in low gonadotropins and low estrogen, is seen in conditions such as amenorrhea due to low weight, stress, or Sheehan syndrome. Uterine abnormalities, such as fibroids, may also contribute to infertility, but this is not consistent with the clinical findings in this case. Hypergonadotropic hypoestrogenic anovulation, which is characterized by high levels of gonadotropins but unresponsive ovaries and low estrogen levels, is more commonly seen in conditions such as Turner’s syndrome, primary ovarian failure, or ovary damage.

Understanding Ovulation Induction and Its Categories

Ovulation induction is a common treatment for couples who have difficulty conceiving naturally due to ovulation disorders. The process of ovulation requires a balance of hormones and feedback loops between the hypothalamus, pituitary gland, and ovaries. Anovulation can occur due to alterations in this balance, which can be classified into three categories: hypogonadotropic hypogonadal anovulation, normogonadotropic normoestrogenic anovulation, and hypergonadotropic hypoestrogenic anovulation. The goal of ovulation induction is to induce mono-follicular development and subsequent ovulation, leading to a singleton pregnancy.

There are various forms of ovulation induction, starting with the least invasive and simplest management option first. Exercise and weight loss are typically the first-line treatment for patients with polycystic ovarian syndrome, as ovulation can spontaneously return with even a modest 5% weight loss. Letrozole is now considered the first-line medical therapy for patients with PCOS due to its reduced risk of adverse effects on endometrial and cervical mucous compared to clomiphene citrate. Clomiphene citrate is a selective estrogen receptor modulator that acts primarily at the hypothalamus, blocking the negative feedback effect of estrogens. Gonadotropin therapy tends to be the treatment used mostly for women with hypogonadotropic hypogonadism.

One potential side effect of ovulation induction is ovarian hyperstimulation syndrome (OHSS), which can be life-threatening if not identified and managed promptly. OHSS occurs when ovarian enlargement with multiple cystic spaces form, and an increase in the permeability of capillaries leads to a fluid shift from the intravascular to the extra-vascular space. The severity of OHSS varies, with the risk of severe OHSS occurring in less than 1% of all women undergoing ovarian induction. Management includes fluid and electrolyte replacement, anticoagulation therapy, abdominal ascitic paracentesis, and pregnancy termination to prevent further hormonal imbalances.

During pregnancy, a woman’s body undergoes various physiological changes. The cardiovascular system experiences an increase in stroke volume, heart rate, and cardiac output, while systolic blood pressure remains unchanged and diastolic blood pressure decreases in the first and second trimesters before returning to normal levels by term. The enlarged uterus may cause issues with venous return, leading to ankle swelling, supine hypotension, and varicose veins.

The respiratory system sees an increase in pulmonary ventilation and tidal volume, with oxygen requirements only increasing by 20%. This can lead to a sense of dyspnea due to over-breathing and a fall in pCO2. The basal metabolic rate also increases, potentially due to increased thyroxine and adrenocortical hormones.

Maternal blood volume increases by 30%, with red blood cells increasing by 20% and plasma increasing by 50%, leading to a decrease in hemoglobin levels. Coagulant activity increases slightly, while fibrinolytic activity decreases. Platelet count falls, and white blood cell count and erythrocyte sedimentation rate rise.

The urinary system experiences an increase in blood flow and glomerular filtration rate, with elevated sex steroid levels leading to increased salt and water reabsorption and urinary protein losses. Trace glycosuria may also occur.

Calcium requirements increase during pregnancy, with gut absorption increasing substantially due to increased 1,25 dihydroxy vitamin D. Serum levels of calcium and phosphate may fall, but ionized calcium levels remain stable. The liver experiences an increase in alkaline phosphatase and a decrease in albumin levels.

The uterus undergoes significant changes, increasing in weight from 100g to 1100g and transitioning from hyperplasia to hypertrophy. Cervical ectropion and discharge may increase, and Braxton-Hicks contractions may occur in late pregnancy. Retroversion may lead to retention in the first trimester but usually self-corrects.